Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David E Lanar

Showing results (11-20 of 63) with videos related to

Pageof 7
Sort By:
Malaria Journal|June 28, 2008
Polymorphism patterns in Duffy-binding protein among Thai Plasmodium vivax isolatesPanita Gosi, Srisin Khusmith, Thareerat Khalambaheti, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|June 9, 2015
Optimizing the design of protein nanoparticles as carriers for vaccine applicationsTais A P F Doll, Tobias Neef, Nha Duong, et al.
Infection and Immunity|March 24, 2005
Process development and analysis of liver-stage antigen 1, a preerythrocyte-stage protein-based vaccine for Plasmodium falciparumCollette J Hillier, Lisa A Ware, Arnoldo Barbosa, et al.
Vaccine|April 17, 2014
Effectiveness of a novel immunogenic nanoparticle platform for Toxoplasma peptide vaccine in HLA transgenic miceKamal El Bissati, Ying Zhou, Debleena Dasgupta, et al.
Journal of Nanobiotechnology|September 8, 2017
The use of a P. falciparum specific coiled-coil domain to construct a self-assembling protein nanoparticle vaccine to prevent malariaChristopher P Karch, Tais A P F Doll, Sara M Paulillo, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 17, 2009
A nonadjuvanted polypeptide nanoparticle vaccine confers long-lasting protection against rodent malariaStephen A Kaba, Clara Brando, Qin Guo, et al.
Infection and Immunity|January 24, 2008
Duration of naturally acquired antibody responses to blood-stage Plasmodium falciparum is age dependent and antigen specificOnome J Akpogheneta, Nancy O Duah, Kevin K A Tetteh, et al.
The Journal of Infectious Diseases|February 16, 2008
Antibodies to pre-erythrocytic Plasmodium falciparum antigens and risk of clinical malaria in Kenyan childrenChandy C John, Aaron J Tande, Ann M Moormann, et al.
Infection and Immunity|January 27, 2004
Measurement of antibody levels against region II of the erythrocyte-binding antigen 175 of Plasmodium falciparum in an area of malaria holoendemicity in western KenyaEunita A Ohas, John H Adams, John N Waitumbi, et al.
Infection and Immunity|August 23, 2005
Merozoite surface protein 1 of Plasmodium vivax induces a protective response against Plasmodium cynomolgi challenge in rhesus monkeysSheetij Dutta, Deep C Kaushal, Lisa A Ware, et al.
Pageof 7

Showing results (11-20 of 63) with videos related to

Sort By:
Pageof 7
Malaria Journal|June 28, 2008
Polymorphism patterns in Duffy-binding protein among Thai Plasmodium vivax isolatesPanita Gosi, Srisin Khusmith, Thareerat Khalambaheti, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|June 9, 2015
Optimizing the design of protein nanoparticles as carriers for vaccine applicationsTais A P F Doll, Tobias Neef, Nha Duong, et al.
Infection and Immunity|March 24, 2005
Process development and analysis of liver-stage antigen 1, a preerythrocyte-stage protein-based vaccine for Plasmodium falciparumCollette J Hillier, Lisa A Ware, Arnoldo Barbosa, et al.
Vaccine|April 17, 2014
Effectiveness of a novel immunogenic nanoparticle platform for Toxoplasma peptide vaccine in HLA transgenic miceKamal El Bissati, Ying Zhou, Debleena Dasgupta, et al.
Journal of Nanobiotechnology|September 8, 2017
The use of a P. falciparum specific coiled-coil domain to construct a self-assembling protein nanoparticle vaccine to prevent malariaChristopher P Karch, Tais A P F Doll, Sara M Paulillo, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 17, 2009
A nonadjuvanted polypeptide nanoparticle vaccine confers long-lasting protection against rodent malariaStephen A Kaba, Clara Brando, Qin Guo, et al.
Infection and Immunity|January 24, 2008
Duration of naturally acquired antibody responses to blood-stage Plasmodium falciparum is age dependent and antigen specificOnome J Akpogheneta, Nancy O Duah, Kevin K A Tetteh, et al.
The Journal of Infectious Diseases|February 16, 2008
Antibodies to pre-erythrocytic Plasmodium falciparum antigens and risk of clinical malaria in Kenyan childrenChandy C John, Aaron J Tande, Ann M Moormann, et al.
Infection and Immunity|January 27, 2004
Measurement of antibody levels against region II of the erythrocyte-binding antigen 175 of Plasmodium falciparum in an area of malaria holoendemicity in western KenyaEunita A Ohas, John H Adams, John N Waitumbi, et al.
Infection and Immunity|August 23, 2005
Merozoite surface protein 1 of Plasmodium vivax induces a protective response against Plasmodium cynomolgi challenge in rhesus monkeysSheetij Dutta, Deep C Kaushal, Lisa A Ware, et al.
Pageof 7